Personalized Cancer Treatments Approach Tipping Point

Significant cost reductions for genome sequencing are bringing personalized medicine into better focus. But payers are lagging and providers may struggle to build up the necessary infrastructure before it becomes the standard of care.

Name:
E-mail:
Website:
Please enter your comment below:

Please enter the text below: